OmniStar Financial Group »

Intra Cellular Therapies shares owned by OmniStar Financial Group

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by OmniStar Financial Group from 13F filings

Historical chart of OmniStar Financial Group investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by OmniStar Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by OmniStar Financial Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $672k 9.7k 69.20

More positions owned by OmniStar Financial Group

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Apple (AAPL)
Abrdn Silver Etf Trust Physcl Silvr Shs (SIVR)
Abbvie (ABBV)
Target Corporation (TGT)
Amgen (AMGN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Home Depot (HD)
NetApp (NTAP)
Corebridge Finl (CRBG)
Vanguard Index Fds Real Estate Etf (VNQ)
Cummins (CMI)
Kimberly-Clark Corporation (KMB)

View all positions for OmniStar Financial Group

Top funds holding Intra Cellular Therapies

Vanguard Group
Daniel D. Thurber
Bellevue Group
venBio Select Advisor
Jpmorgan Chase & Co
Alliancebernstein
Franklin Resources
Wellington Management Company
Jennifer Ranahan
ClearBridge Advisors
Holocene Advisors
T. Rowe Price Associates
Norges Bank Investment Management
Charles Schwab Investment Management
Lord, Abbett & Co

View all funds holding Intra Cellular Therapies